<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJMM</journal-id><journal-title-group><journal-title>Open Journal of Medical Microbiology</journal-title></journal-title-group><issn pub-type="epub">2165-3372</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojmm.2023.131004</article-id><article-id pub-id-type="publisher-id">OJMM-123205</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Prevalence of Extended-Spectrum Beta-Lactamase-Producing Strains Isolated at Zinder National Hospital (ZNH) in 2021 and Their Antibiotic Susceptibility Profile
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maman</surname><given-names>Sani Falissou Saïdou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoulaye</surname><given-names>Ousmane</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoulaye</surname><given-names>Inoussa</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoulaye</surname><given-names>Maman Bachir</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hassane</surname><given-names>Boureima</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lo</surname><given-names>Gora</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alhousseini</surname><given-names>Maiga Daouda</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Doutchi</surname><given-names>Mahamadou</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bako</surname><given-names>Saley Mahaman Laouali</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sidi</surname><given-names>Maman Bacha Boukar</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Saidou</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff5"><addr-line>Faculté des Sciences de la Santé, Université Abdou Moumouni, Niamey, Niger</addr-line></aff><aff id="aff1"><addr-line>H&amp;amp;#244;pital National de Zinder, Zinder, Niger</addr-line></aff><aff id="aff2"><addr-line>Faculté des Sciences de la Santé, Université Dan Dicko Dankoulodo de Maradi, Maradi, Niger</addr-line></aff><aff id="aff4"><addr-line>Faculté de Médecine, de Pharmacie et d’odontostomatologie, Université Cheikh Anta Diop de Dakar, Dakar, Sénégal</addr-line></aff><aff id="aff3"><addr-line>Centre de Recherche Médicale et Sanitaire, Niamey, Niger</addr-line></aff><aff id="aff6"><addr-line>Faculté des Sciences de la Santé, Université de Zinder, Zinder, Niger</addr-line></aff><pub-date pub-type="epub"><day>19</day><month>01</month><year>2023</year></pub-date><volume>13</volume><issue>01</issue><fpage>43</fpage><lpage>51</lpage><history><date date-type="received"><day>8,</day>	<month>September</month>	<year>2022</year></date><date date-type="rev-recd"><day>20,</day>	<month>February</month>	<year>2023</year>	</date><date date-type="accepted"><day>23,</day>	<month>February</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Purpose: </b>
  Bacterial resistance to antibiotics has become a global public health problem. Enterobacteriaceae ESBL is among the most incriminated in this emergence which reduces the therapeutic possibilities. Thus, the objective of this study is to determine the prevalence of the extended-spectrum beta-
   
  lactamase
   (ESBL) producing Enterobacteriaceae at ZNH and their antibiotic susceptibility profile. <b>Materials and Methods:</b> This is a prospective study carried out over 5 months in all hospitalized and non-hospitalized patients in whom a culture was taken for the diagnosis of an infection. The search for ESBL is done by the double disc diffusion method. <b>Results:</b> In total, 21 out of 45 of our strains are ESBL-producing, i.e. a frequency of 46.7%.
   
  The mean age is 41.62 (&#177;22.90) with extremes of 2.6
   
  -
   
  78 years. The distribution of ESBL producing species showed a predominance of E. coli with 66.7% followed by K. pneumoniae and K. oxytoca each 9.5%. All ESBL strains were resistant to Amoxicillin, Cefalotin, Pipiracillin, Piperacillin
   
  +
   
  tazobactam, Ticarcillin, Ticarcillin
   
  +
   
  clavulanic acid. Resistance to C3G and Aztreonam was each 95.5%, to Amoxicillin/clavulanic acid 9.1%. All strains were sensitive to imipenem. E. coli strains showed resistance: 85.7% to ciprofloxacin, 50% to Amikacin, 57.1% to Gentamicin. For K. pneumoniae, it is 66.7% for Gentamicin and Ciprofloxacin. <b>Conclusion:</b> Our study reports a high prevalence of ESBL at the HNZ. This must be taken into account in order to monitor this phenomenon which constitutes a public health problem. The study also reports sensitivity to Amoxicillin/clavulanic acid and Aminoside which can be an alternative.
 
</p></abstract><kwd-group><kwd>Bacterial Resistance</kwd><kwd> ESBL</kwd><kwd> Enterobacteriaceae</kwd><kwd> Zinder</kwd><kwd> Niger</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Bacterial resistance is a phenomenon that was discovered soon after the first antibiotic molecules were used [<xref ref-type="bibr" rid="scirp.123205-ref1">1</xref>] . According to a global report, more than 1.2 million people died worldwide in 2019 from infections caused by antibiotic-resistant bacteria [<xref ref-type="bibr" rid="scirp.123205-ref2">2</xref>] . Extended-spectrum beta-lactamase (ESBL)-secreting Enterobacteriaceae are a major contributor to the emergence of resistance. These are bacteria that have the ability to hydrolyze the beta-lactam ring of all penicillin making it inactive, with the exception of Cephamycin and Carbapenem. This reduces the therapeutic arsenal, creates a deadlock situation and has a considerable economic impact [<xref ref-type="bibr" rid="scirp.123205-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.123205-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.123205-ref5">5</xref>] . This situation constitutes a real threat to global public health, which is why the WHO has made it a priority [<xref ref-type="bibr" rid="scirp.123205-ref6">6</xref>] .</p><p>In Africa the prevalence of ESBL varies between 30% - 50% during infectious processes. In Ghana, half of the Enterobacteriaceae (49.4%) isolated from various infections diagnosed at Korle-Bu Hospital were ESBL producers [<xref ref-type="bibr" rid="scirp.123205-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.123205-ref8">8</xref>] . Although ESBLs have been described in some African countries, there is no information on ESBLs here. In view of these results, an effective control plan is needed. This plan will start with a prevalence study to confirm and know the level of progress of this obstacle. The objective of this study is to determine the prevalence of ESBL and their sensitivities to the different families of antibiotics in the National Hospital of Zinder (NHZ) to better enable us to deal with the problem and guide the choice of prescriptions.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>We conducted a prospective descriptive study at the National Hospital of Zinder (HNZ) over a period of 6 months from June to December 2021 to determine the prevalence of ESBL and their susceptibility to different families of antibiotics. Our study population consisted of inpatients and outpatients in whom a bacteriological examination was requested for the diagnosis of any infection with as inclusion criteria, patients from whom an Enterobacteriaceae was isolated.</p><p>The sample size was not calculated. We contacted each other to collect the strains depending on the time.</p><p>Excluded from our study were any individuals from whom a non-Enterobacteriaceae was isolated, a sample or a bulletin that did not comply with the criteria established by the laboratory. Ethical aspects such as research authorization by the NHZ and preservation of anonymity were respected.</p><p>The strains of Enterobacteriaceae in our study were isolated from various pathological products which were analyzed in the NHZ Laboratory Bacteriology Unit using conventional bacteriological techniques and procedures [<xref ref-type="bibr" rid="scirp.123205-ref9">9</xref>] .</p><p>Macroscopic, cytobacteriological examination was performed on all samples. Urine was inoculated on CLED medium. For stools, MacConkey medium with sorbitol, Hektoen were used. Colonies suspected on Hektoen were plated in Kligler-Hajna. Plus, in addition to Mac Conkey, CLED, we used fresh blood agar under CO<sub>2</sub>. The reading is done after 24 hours and an examination after staining is done on a colony confirming the purity (Gram control). We used the API 20E gallery (Bio M&#233;rieux, France) for strain identification.</p><p>We used the agar diffusion method to interpret the critical diameter of the inhibition zones also according to the table established by CA-SFM/ EUCAST2020 [<xref ref-type="bibr" rid="scirp.123205-ref10">10</xref>] .</p><p>Penicillin such as Amoxicillin, Amoxicillin/clavulanic acid, Ticarcillin, Ticarcillin + clavulanate, Piperacillin, Piperacillin + tazobactam, Cefalotin, Cefoxitin, Ceftriaxone, Cefotaxime, Cefepime, Ceftazidime, Aztreonam and Imipenem were tested. Some aminosides were also tested including Gentamicin, Tobramicyn and Amikacin. Only Ciprofloxacin of the quinolone family was tested. The sensitivity of colistin was also studied.</p><p>We used the phenotypic method. Double disc synergy technique, between discs of third generation cephalosporins (Cefotaxime, Ceftazidime, Ceftriaxone etc) and a disc containing the combination Amoxicillin/clavulanic acid (a β-lactamase inhibitor). This synergy results in the formation of an image known as a champagne cork, which indicates the restoration of the activity of C3Gs opposite the Amoxicillin/clavulanic acid combination [<xref ref-type="bibr" rid="scirp.123205-ref11">11</xref>] .</p><p>The data were processed and analyzed using Epi info 3.5.4 and Excel 2010. Variables such as socio-demographic characteristics, nature of the specimen and service their behavior towards antibiotics was effectively investigated.</p></sec><sec id="s3"><title>3. Results</title><p>In our study, fifty (50) strains of Enterobacteriaceae were isolated from the different specimens. Blood culture was not performed in our study. <xref ref-type="table" rid="table1">Table 1</xref> shows the distribution of Enterobacteriaceae species. Ten (10) different species of Enterobacteriaceae were isolated including Citobacter koseri, Escherichia coli, Klebsiella ornithinolytica, Klebsiella oxytoca, Klebsiella pneumoniae, Morganella morganii, Proteus mirabilis, Providencia stuartii, Salmonella Spp, Serratia odifera. Among them Escherichia coli was the most isolated species (62%) followed by Klebsiella pneumoniae (6 12%). Of these fifty (50) strains, twenty-one (21) were beta-lactamase producing, i.e. a prevalence of 42.0%. A clear male predominance with 71.4% was observed. Female represented only 28.6%. Urine is the product from which most ESBL strains have been isolated. E. coli was the most isolated species in both specimens.</p><p><xref ref-type="table" rid="table2">Table 2</xref> shows the distribution of strains according to services and environment. Outpatients are in the majority with a frequency of 61.9% (n = 13). In the inpatient population, the nephrology department reported more EBLSE strains (23.8%), P = 0.207.</p><p><xref ref-type="fig" rid="fig1">Figure 1</xref> shows the resistance of the beta-lactamase producing strains to the beta-lactams. All strains n = 21 (100%) were resistant to: Amoxicillin, Ticarcillin, Ticarcillin + ac clavulanic, Piperacillin, Piperacillin-tazobactam, first and third generation Cephalosporins (C1 and C3) and Aztreonam. However, all n = 21 (100%) strains were susceptible to Imipenem and 90.5% were susceptible to Amoxicillin/clavulanic acid. A 45% resistance to Cefoxitin was found.</p><p>Resistance to aminoglycosides including Gentamicin, Tobramicyn and Amikacin was 66.7%, 61.9% and 47.6% respectively. Strains were resistant to ciprofloxacin at a frequency of 85.7% (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of Enterobacteriaceae strains and their frequencies</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Species</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Citobacter koseri</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.0%</td></tr><tr><td align="center" valign="middle" >Escherichia coli</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >62.0%</td></tr><tr><td align="center" valign="middle" >Klebsiella ornithinolytica</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.0%</td></tr><tr><td align="center" valign="middle" >Klebsiella oxytoca</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4.0%</td></tr><tr><td align="center" valign="middle" >Klebsiella pneumoniae</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >12.0%</td></tr><tr><td align="center" valign="middle" >Morganella morganii</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.0%</td></tr><tr><td align="center" valign="middle" >Proteus mirabilis</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >6.0%</td></tr><tr><td align="center" valign="middle" >Providencia stuartii</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.0%</td></tr><tr><td align="center" valign="middle" >Salmonella Spp</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4.0%</td></tr><tr><td align="center" valign="middle" >Serratia odifera</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4.0%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of ESBL strains by department and environment</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Species</th><th align="center" valign="middle" >Surgery</th><th align="center" valign="middle" >External</th><th align="center" valign="middle" >Medicine/women</th><th align="center" valign="middle" >Nephrology</th></tr></thead><tr><td align="center" valign="middle" >Escherichia coli</td><td align="center" valign="middle" >1 (4.76%)</td><td align="center" valign="middle" >9 (42.85%)</td><td align="center" valign="middle" >1 (4.76%)</td><td align="center" valign="middle" >3 (14.28%)</td></tr><tr><td align="center" valign="middle" >Klebsiella ornithinolytica</td><td align="center" valign="middle" >1 (4.76%)</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >0 (0%)</td></tr><tr><td align="center" valign="middle" >Klebsiella oxytoca</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >1 (4.76%)</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >1 (4.76%)</td></tr><tr><td align="center" valign="middle" >Klebsiella pneumoniae</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >2 (9.52%)</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >0 (0%)</td></tr><tr><td align="center" valign="middle" >Morganella morganii</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >1 (4.76%)</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >0 (0%)</td></tr><tr><td align="center" valign="middle" >Serratia odifera</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >1 (4.76%)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >2 (9.52%)</td><td align="center" valign="middle" >13 (61.90%)</td><td align="center" valign="middle" >1 (4.76%)</td><td align="center" valign="middle" >5 (23.80%)</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussions</title><p>At the end of our study, 42.0% of the isolated strains were extended spectrum beta-lactamase spectrum beta-lactamase. This prevalence is alarmingly high in many African countries [<xref ref-type="bibr" rid="scirp.123205-ref8">8</xref>] . In Togo, Toudji and al report a prevalence of 22.44% [<xref ref-type="bibr" rid="scirp.123205-ref12">12</xref>] . A much lower prevalence (12.5%) was reported in Mali and 12.2% in Morocco in urinary tract infections [<xref ref-type="bibr" rid="scirp.123205-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.123205-ref14">14</xref>] . This is probably due to the lack of adequate surveillance and antimicrobial use in the region. It has been shown that the lack of resources (human and financial) in our countries where hygiene is poor and antibiotics are poorly used, the absence of an antimicrobial surveillance program, increases the risk of the emergence and spread of multidrug resistant bacteria [<xref ref-type="bibr" rid="scirp.123205-ref8">8</xref>] . In contrast, a much higher value was found in Kano (Nigeria) at 66.7% [<xref ref-type="bibr" rid="scirp.123205-ref15">15</xref>] . Here, as in other African countries, antibiotics can be bought over the counter without a prescription. The sale of a few tablets is possible when the patient does not have enough money. Still many patients interrupt the treatment as soon as they feel better before the end of the treatment, keep the remaining tablets in bad condition, for another time or give them to another person with similar complaints without even medical advice [<xref ref-type="bibr" rid="scirp.123205-ref16">16</xref>] .</p><p>The anatomical characteristics of the female urethra are short, wide, straight and close to the perianal area [<xref ref-type="bibr" rid="scirp.123205-ref17">17</xref>] . Despite these factors favoring infection, male sex was dominant with a sex ratio of 1.38 in favor of males. Our results disagree with those reported by Mohamed Sbiti and coll. in Morocco [<xref ref-type="bibr" rid="scirp.123205-ref14">14</xref>] . This can be explained by the socio-cultural aspect in our women (modesty, embarrassment to consult for urinary/vaginal infections). They are generally treated with probabilistic antibiotics.</p><p>In our study, strains from the outside environment were the most frequently isolated with a frequency of 61.9%. Long limited to the hospital setting, the epidemiology of EBLSE has changed considerably since the 2000s. Since then, EBLSE have been spreading in the community [<xref ref-type="bibr" rid="scirp.123205-ref18">18</xref>] . Escherichia coli were the most isolated species with a frequency of 66.7%. Similar results were reported by Ou&#233;draogo in Burkina Faso (67.5%) [<xref ref-type="bibr" rid="scirp.123205-ref16">16</xref>] . This result can be explained by the promiscuity of the anal and urinary orifice, self-infection is possible. On the one hand Escherichia Coli has factors such as adhesion through which it clings to the epithelial cells of the urinary tract. This mechanism makes it the most incriminated in urinary tract infections [<xref ref-type="bibr" rid="scirp.123205-ref19">19</xref>] . However, Anastay and Coll. in France and Belmonte et al. in Reunion Island report E. cloacae as the most isolated species [<xref ref-type="bibr" rid="scirp.123205-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.123205-ref21">21</xref>] . The genera Salmonella, Shigella and Yersinia have not been found due to their rare isolation in the samples analyzed [<xref ref-type="bibr" rid="scirp.123205-ref12">12</xref>] .</p><p>The resistance phenotypes of ESBL strains to different antibiotic families showed 100% resistance to all beta-lactams except Imipenem and Cefoxitin. Both molecules have a methoxyl-0-CH3 radical on the beta-lactam nucleus which protects them from enzyme action. The low resistance observed is probably due to the overexpression of chromosomal cephalosporinase [<xref ref-type="bibr" rid="scirp.123205-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.123205-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.123205-ref23">23</xref>] . Resistance to the Amoxicillin/clavulanate combination was 9.5%. Higher results were reported by Ahoyo in Benin and Mahamat in France [<xref ref-type="bibr" rid="scirp.123205-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.123205-ref25">25</xref>] .</p><p>Resistance to aminoglycosides was lower than that observed with beta-lactams. These antibiotics are difficult to access compared to beta-lactams. Their toxicity is sometimes more remarkable and there are only injectable forms, which limits self-medication [<xref ref-type="bibr" rid="scirp.123205-ref12">12</xref>] . On the other hand, Ciprofloxacin, a widely used antibiotic, was 85.7% resistant. The same finding was made by Mutasim and coll. in Sudan [<xref ref-type="bibr" rid="scirp.123205-ref26">26</xref>] . This level of resistance to Aminosides and Ciprofloxacin may be due to the fact that the plasmid carrying the beta-lactam resistance gene may also carry other resistance genes such as QnrA (quinolone resistance gene) [<xref ref-type="bibr" rid="scirp.123205-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.123205-ref28">28</xref>] .</p><p>Finally, the limitations of this study remain the non-availability of certain materials and reagents to continue the analysis of the isolated bacterial strains.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Our study revealed a high prevalence of EBLSE of 42% Escherichia coli was the most isolated species (62%) followed by Klebsiella pneumoniae (12%). Cross-resistance to other families of antibiotics including aminoside and quinolon was observed. This must be taken into account in order to curb this scourge which constitutes a real public health problem. Studies on the circulating gene will allow us to know more about these beta-lactamases.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Sa&#239;dou, M.S.F., Ousmane, A., Inoussa, A., Bachir, A.M., Boureima, H., Gora, L., Daouda, A.M., Mahamadou, D., Laouali, B.S.M., Boukar, S.M.B. and Saidou, M. (2023) Prevalence of Extended-Spectrum Beta-Lactamase-Producing Strains Isolated at Zinder National Hospital (ZNH) in 2021 and Their Antibiotic Susceptibility Profile. Open Journal of Medical Microbiology, 13, 43-51. https://doi.org/10.4236/ojmm.2023.131004</p></sec></body><back><ref-list><title>References</title><ref id="scirp.123205-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Ruppé, E. (2010) épidémiologie des bêta-lactamases à spectre élargi: L’Avènement des CTX-M. Antibiotiques, 12, 3-16. https://doi.org/10.1016/j.antib.2010.01.003</mixed-citation></ref><ref id="scirp.123205-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Roxby, P. (2022) Résistance aux antimicrobiens: Des millions de personnes meurent d'infections, selon un rapport mondial. BBC News Afrique. https://www.bbc.com/afrique/monde-60069604</mixed-citation></ref><ref id="scirp.123205-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Philippon, A. (2013) Les bêta-lactamases à spectre élargi ou étendu (BLSE). Immuno- Analyse &amp; Biologie Spécialisée, 28, 287-96.https://doi.org/10.1016/j.immbio.2013.04.006</mixed-citation></ref><ref id="scirp.123205-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Vora, S. and Auckenthaler, R. (2009) Que signifie “bêtalactamases à spectre élargi” en pratique? Revue Médicale Suisse, 5, 1991-1994. https://www.revmed.ch/revue-medicale-suisse/2009/revue-medicale-suisse-220/que-signifie-betalactamases-a-spectre-elargi-en-pratique#tab=tab-read</mixed-citation></ref><ref id="scirp.123205-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Cattoir, V. and Bicêtre, F. (2008) Les nouvelles bêta-lactamases à spectre étendu (BLSE). Pathologie Infectieuse en Réanimation, MAPAR, 2008, 204-209.</mixed-citation></ref><ref id="scirp.123205-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Résistance aux antibiotiques. Institut Pasteur.https://www.pasteur.fr/fr/centre-medical/fiches-maladies/resistance-aux-antibiotiques</mixed-citation></ref><ref id="scirp.123205-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Feglo, P., Adu-Sarkodie, Y., Ayisi, L., Jain, R., Spurbeck, R.R., et al. (2013) Emergence of a Novel Extended-Spectrum-β-Lactamase (ESBL)-Producing, Fluoroquinolone-Resistant Clone of Extraintestinal Pathogenic Escherichia coli in Kumasi, Ghana. Journal of Clinical Microbiology, 51, 728-730. https://doi.org/10.1128/JCM.03006-12</mixed-citation></ref><ref id="scirp.123205-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ouedraogo, A.S., Jean Pierre, H., Ba&amp;#241;uls, A.L., Ouédraogo, R. and Godreuil, S. (2017) émergence et diffusion de la résistance aux antibiotiques en Afrique de l’Ouest: Facteurs favorisants et évaluation de la menace. Médecine et Santé Tropicales, 27, 147-154. https://doi.org/10.1684/mst.2017.0678</mixed-citation></ref><ref id="scirp.123205-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Denis, F., Ploy,M.-C., Martin, C., Bingen, é and Quentin, R. (2007) Bactériologie Médicale: Techniques Usuelles. 3rd Edition, Elsevier, Paris, 543 p.</mixed-citation></ref><ref id="scirp.123205-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">CA-SFM (Comité de l’Antibiogramme de la Société Francaise de Microbiologie), EUCAST (European Commitee on Antimicrobial Susceptibility) (2020) Re- commandations 2020. Vol. 1.1.</mixed-citation></ref><ref id="scirp.123205-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Détection des Bêta-lactamases à spectre étendu (BLSE).https://microbiologie-clinique.com/Detection-beta-lactamases-BLSE.html</mixed-citation></ref><ref id="scirp.123205-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Toudji, A.G., Djeri, B., Karou, S.D., Tigossou, S., Ameyapoh, Y. and de Souza, C. (2017) Prévalence des souches d’entérobactéries productrices de bêta-lactamases à spectre élargi isolées au Togo et de leur sensibilité aux antibiotiques. International Journal of Biological and Chemical Sciences, 11, 65-77. https://doi.org/10.4314/ijbcs.v11i3.19</mixed-citation></ref><ref id="scirp.123205-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Kalambry, A., Gaudré, N., Dramé, B.S., Poudiougo, A., Kassogué, A., Koné, H. and Diarra, A. (2019) Profil de résistance aux bêta-lactamines des entérobactéries isolées des prélèvements urinaires à l’H&amp;#244;pital du Mali. Revue Malienne d’Infectiologie et de Microbiologie, 14, 6-13. https://doi.org/10.53597/remim.v14i2.1363</mixed-citation></ref><ref id="scirp.123205-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sbiti, M., Lahmadi, K. and Louzi, L. (2017) Profil épidémiologique des entérobactéries uropathogènes productrices de bêta-lactamases à spectre élargi. Pan African Medical Journal, 28, Article 29. https://doi.org/10.11604/pamj.2017.28.29.11402</mixed-citation></ref><ref id="scirp.123205-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Yusha’u, M., Aliyu, H., Kumurya, A. and Suleiman, K. (2010) Prevalence of Extended Spectrum β-Lactamases (ESBLs) among Enterobacteriaceae in Murtala Mohammed Specialist Hospital, Kano, Nigeria. Bayero Journal of Pure and Applied Sciences, 3, 169-172. https://doi.org/10.4314/bajopas.v3i1.58756</mixed-citation></ref><ref id="scirp.123205-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ouedraogo, A.-S., Sanou, M., Kissou, A., Sanou, S., Solaré, H., Kaboré, F., et al. (2016) High Prevalence of Extended-Spectrum &amp;#223;-Lactamase Producing enterobacteriaceae among Clinical Isolates in Burkina Faso. BMC Infectious Diseases, 16, Article No. 326. https://doi.org/10.1186/s12879-016-1655-3</mixed-citation></ref><ref id="scirp.123205-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Getaneh, T., Negesse, A., Dessie, G., Desta, M. and Tigabu, A. (2021) Prevalence of Urinary Tract Infection and Its Associated Factors among Pregnant Women in Ethiopia: A Systematic Review and Meta-Analysis. BioMed Research International, 2021, Article ID: 6551526. https://doi.org/10.1155/2021/6551526</mixed-citation></ref><ref id="scirp.123205-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Zahar, J.-R., Bille, E., Schnell, D., Lanternier, F., Mechai, F., Masse, V., et al. (2009) Diffusion communautaire des entérobactéries sécrétrices de β-lactamase à spectre élargi (EBLSE). Medical Sciences (Paris), 25, 939-944.https://doi.org/10.1051/medsci/20092511939</mixed-citation></ref><ref id="scirp.123205-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Infection urinaire: Tout savoir pour la soigner. Qare. https://www.qare.fr/sante/infection-urinaire/</mixed-citation></ref><ref id="scirp.123205-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Anastay, M., Lagier, E., Blanc, V. and Chardon, H. (2013) épidémiologie des bêtalactamases à spectre étendu (BLSE) chez les entérobactéries dans un h&amp;#244;pital du sud de la France, 1999-2007. Pathologie Biologie, 61, 38-43. https://doi.org/10.1016/j.patbio.2012.03.001</mixed-citation></ref><ref id="scirp.123205-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Belmonte, O., Drouet, D., Alba, J., Moiton, M.-P., Kuli, B., Lugagne-Delpon, N., et al. (2010) évolution de la résistance des entérobactéries aux antibiotiques sur l’ile de la Réunion: émergence des bêta-lactamases à spectre élargi. Pathologie Biologie, 58, 18-24. https://doi.org/10.1016/j.patbio.2009.07.021</mixed-citation></ref><ref id="scirp.123205-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Davido, B., Senard, O., Bouchand, F., Deconinck, L., Matt, M., Fellous, L., et al. (2018) Efficacité de la céfoxitine dans les infections urinaires (IU) à E.coli et K.pneumoniae BLSE. Médecine et Maladies Infectieuses, 48, S103.https://doi.org/10.1016/j.medmal.2018.04.257</mixed-citation></ref><ref id="scirp.123205-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Jacoby, G.A. (2009) AmpC β-Lactamases. Clinical Microbiology Reviews, 22, 161-182. https://doi.org/10.1128/CMR.00036-08</mixed-citation></ref><ref id="scirp.123205-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Ahoyo, A.T., Baba-Moussa, L., Anago, A.E., Avogbe, P., Missihoun, T.D., Loko, F., et al. (2007) Incidence d’infections liées à Escherichia coli producteur de bêta lactamase à spectre élargi au Centre hospitalier départemental du Zou et Collines au Bénin. Médecine et Maladies Infectieuses, 37, 746-752.https://doi.org/10.1016/j.medmal.2007.03.004</mixed-citation></ref><ref id="scirp.123205-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Mahamat, A., Lavigne, J.-P., Bouziges, N., Daurès, J.-P. and Sotto, A. (2006) Profils de résistance des souches urinaires de Proteus mirabilis de 1999 à 2005 au CHU de Nimes. Pathologie Biologie, 54, 456-461. https://doi.org/10.1016/j.patbio.2006.07.015</mixed-citation></ref><ref id="scirp.123205-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Ibrahim, M.E., Bilal, N.E., Magzoub, M.A. and Hamid, M.E. (2013) Prevalence of Extended-Spectrum β-Lactamases-Producing Escherichia coli from Hospitals in Khartoum State, Sudan. Oman Medical Journal, 28, 116-120.https://doi.org/10.5001/omj.2013.30</mixed-citation></ref><ref id="scirp.123205-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Paterson, D.L. and Bonomo, R.A. (2005) Extended-Spectrum β-Lactamases: A Clinical Update. Clinical Microbiology Reviews, 18, 657-686. https://doi.org/10.1128/CMR.18.4.657-686.2005</mixed-citation></ref><ref id="scirp.123205-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Aibinu, I.E., Ohaegbulam, V.C., Adenipekun, E.A., Ogunsola, F.T., Odugbemi, T.O. and Mee, B.J. (2003) Extended-Spectrum β-Lactamase Enzymes in Clinical Isolates of Enterobacter Species from Lagos, Nigeria. Journal of Clinical Microbiology, 41, 2197-2200. https://doi.org/10.1128/JCM.41.5.2197-2200.2003</mixed-citation></ref></ref-list></back></article>